Pharmacokinetics and Safety of MB-102 (Relmapirazin) and the MediBeacon Transdermal GFR Measurement System in Evaluation of Kidney Function in Normal and Renal Compromised Subjects
Clinical trial NCT05425719 · COMPLETED
Trial details
- NCT number
- NCT05425719
- Sponsor
- MediBeacon
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-14
- Primary completion
- 2023-02-15
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.